Biosimilars Adoption In Europe, US: Some Wins, 'Incomplete' Policies

 
• By Anju Ghangurde

Industry chieftains and experts, including Sandoz biopharma's global head, deliberated at the recent AAM meeting the status of biosimilars adoption in Europe and trends and opportunities to generate savings for both the US federal government and payers.

biosims
Experts Share Insights On Uptake Of Biosimilars In Europe, US • Source: Alamy

More from Business

More from Scrip